Cost-effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation.

Autoria(s): Llovet i Bayer, Josep Maria; Mas, X.; Aponte, John J.; Fuster Obregón, Josep; Navasa Anadón, Miguel A.; Christensen, E.; Rodés, J.; Bruix Tudó, Jordi
Data(s)

18/02/2014
Identificador

http://hdl.handle.net/2072/223892
Idioma(s)

eng
Publicador

BMJ Group
Direitos

(c) BMJ Publishing Group Ltd and British Society of Gastroenterology, 2002
Palavras-Chave #Trasplantament hepàtic #Anàlisi cost-benefici #Càncer de fetge #Hepatic transplantation #Cost effectiveness #Liver cancer
Tipo

info:eu-repo/semantics/article
Acesso ao item digital